Is CTCX stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Carmell Therapeutics 10 years ago, but if you had invested on Thursday 23rd of September 2021 when the price was $9.75, you would have made a loss of $-9.50 per share or -97.48%
Yes, the average daily trading liquidity for Carmell Therapeutics is $1.72 million. You should therefore be able to get in and out of your positions relatively fast.
Carmell Therapeutics has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. Carmell Therapeutics has a very good net profit margin of 211.88% and should have very high tolerances against inflation.
We have calculated the inflation risk for Carmell Therapeutics to be low [0.45 out of 1]